These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 25867024)
1. Role of ALADIN in human adrenocortical cells for oxidative stress response and steroidogenesis. Jühlen R; Idkowiak J; Taylor AE; Kind B; Arlt W; Huebner A; Koehler K PLoS One; 2015; 10(4):e0124582. PubMed ID: 25867024 [TBL] [Abstract][Full Text] [Related]
2. Deficiency of ALADIN impairs redox homeostasis in human adrenal cells and inhibits steroidogenesis. Prasad R; Metherell LA; Clark AJ; Storr HL Endocrinology; 2013 Sep; 154(9):3209-18. PubMed ID: 23825130 [TBL] [Abstract][Full Text] [Related]
3. Compensation for chronic oxidative stress in ALADIN null mice. Jühlen R; Peitzsch M; Gärtner S; Landgraf D; Eisenhofer G; Huebner A; Koehler K Biol Open; 2018 Jan; 7(1):. PubMed ID: 29362278 [TBL] [Abstract][Full Text] [Related]
4. ALADINI482S causes selective failure of nuclear protein import and hypersensitivity to oxidative stress in triple A syndrome. Hirano M; Furiya Y; Asai H; Yasui A; Ueno S Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2298-303. PubMed ID: 16467144 [TBL] [Abstract][Full Text] [Related]
5. Identification of a novel putative interaction partner of the nucleoporin ALADIN. Jühlen R; Landgraf D; Huebner A; Koehler K Biol Open; 2016 Nov; 5(11):1697-1705. PubMed ID: 27754849 [TBL] [Abstract][Full Text] [Related]
6. The triple A syndrome is due to mutations in ALADIN, a novel member of the nuclear pore complex. Huebner A; Kaindl AM; Knobeloch KP; Petzold H; Mann P; Koehler K Endocr Res; 2004 Nov; 30(4):891-9. PubMed ID: 15666842 [TBL] [Abstract][Full Text] [Related]
7. Deficiency of ferritin heavy-chain nuclear import in triple a syndrome implies nuclear oxidative damage as the primary disease mechanism. Storr HL; Kind B; Parfitt DA; Chapple JP; Lorenz M; Koehler K; Huebner A; Clark AJ Mol Endocrinol; 2009 Dec; 23(12):2086-94. PubMed ID: 19855093 [TBL] [Abstract][Full Text] [Related]
8. Triple-A Syndrome (TAS): An In-Depth Overview on Genetic and Phenotype Heterogeneity. Pogliaghi G; Cangiano B; Duminuco P; Vezzoli V; Bonomi M Protein Pept Lett; 2020; 27(12):1192-1203. PubMed ID: 32533814 [TBL] [Abstract][Full Text] [Related]
9. The nuclear pore complex protein ALADIN is mislocalized in triple A syndrome. Cronshaw JM; Matunis MJ Proc Natl Acad Sci U S A; 2003 May; 100(10):5823-7. PubMed ID: 12730363 [TBL] [Abstract][Full Text] [Related]
10. The NCI-H295 cell line: a pluripotent model for human adrenocortical studies. Rainey WE; Bird IM; Mason JI Mol Cell Endocrinol; 1994 Apr; 100(1-2):45-50. PubMed ID: 8056157 [TBL] [Abstract][Full Text] [Related]
11. Tissue-specific expression and subcellular localization of ALADIN, the absence of which causes human triple A syndrome. Cho AR; Yang KJ; Bae Y; Bahk YY; Kim E; Lee H; Kim JK; Park W; Rhim H; Choi SY; Imanaka T; Moon S; Yoon J; Yoon SK Exp Mol Med; 2009 Jun; 41(6):381-6. PubMed ID: 19322026 [TBL] [Abstract][Full Text] [Related]
12. The transmembrane nucleoporin NDC1 is required for targeting of ALADIN to nuclear pore complexes. Yamazumi Y; Kamiya A; Nishida A; Nishihara A; Iemura S; Natsume T; Akiyama T Biochem Biophys Res Commun; 2009 Nov; 389(1):100-4. PubMed ID: 19703420 [TBL] [Abstract][Full Text] [Related]
13. Cellular localization of 17 natural mutant variants of ALADIN protein in triple A syndrome - shedding light on an unexpected splice mutation. Krumbholz M; Koehler K; Huebner A Biochem Cell Biol; 2006 Apr; 84(2):243-9. PubMed ID: 16609705 [TBL] [Abstract][Full Text] [Related]
14. The nuclear pore complex protein ALADIN is anchored via NDC1 but not via POM121 and GP210 in the nuclear envelope. Kind B; Koehler K; Lorenz M; Huebner A Biochem Biophys Res Commun; 2009 Dec; 390(2):205-10. PubMed ID: 19782045 [TBL] [Abstract][Full Text] [Related]
16. Mice lacking the nuclear pore complex protein ALADIN show female infertility but fail to develop a phenotype resembling human triple A syndrome. Huebner A; Mann P; Rohde E; Kaindl AM; Witt M; Verkade P; Jakubiczka S; Menschikowski M; Stoltenburg-Didinger G; Koehler K Mol Cell Biol; 2006 Mar; 26(5):1879-87. PubMed ID: 16479006 [TBL] [Abstract][Full Text] [Related]
17. Changes in differential gene expression in fibroblast cells from patients with triple A syndrome under oxidative stress. Koehler K; End K; Kind B; Landgraf D; Mitzscherling P; Huebner A Horm Metab Res; 2013 Feb; 45(2):102-8. PubMed ID: 23315990 [TBL] [Abstract][Full Text] [Related]
18. Spectrum of mutations of the AAAS gene in Allgrove syndrome: lack of mutations in six kindreds with isolated resistance to corticotropin. Sandrini F; Farmakidis C; Kirschner LS; Wu SM; Tullio-Pelet A; Lyonnet S; Metzger DL; Bourdony CJ; Tiosano D; Chan WY; Stratakis CA J Clin Endocrinol Metab; 2001 Nov; 86(11):5433-7. PubMed ID: 11701718 [TBL] [Abstract][Full Text] [Related]
19. Functional validation of a novel AAAS variant in an atypical presentation of Allgrove syndrome. Macke EL; Morales-Rosado JA; Macklin-Mantia SK; Schmitz CT; Oskarsson B; Klee EW; Wierenga KJ Mol Genet Genomic Med; 2022 Jul; 10(7):e1966. PubMed ID: 35570467 [TBL] [Abstract][Full Text] [Related]
20. Differential regulation of glucocorticoid synthesis in murine intestinal epithelial versus adrenocortical cell lines. Mueller M; Atanasov A; Cima I; Corazza N; Schoonjans K; Brunner T Endocrinology; 2007 Mar; 148(3):1445-53. PubMed ID: 17170096 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]